Global Anophthalmia and Microphthalmia Market -Scenario Anophthalmia and microphthalmia mean the absence of an eye and the presence of a small eye within the orbit. Anophthalmia and microphthalmia are interchangeable. Whereas, microphthalmia is a disorder in which one or both eyes are abnormally small, while anophthalmia is the absence of one or both eyes. Anophthalmia and microphthalmia mostly occur during pregnancy. However, anophthalmia and microphthalmia often result in blindness or limited vision. It is a rare disorder and the severe case has treatment unavailability. Request Sample with New Market Trends @ https://www.marketresearchfuture.com/sample_request/4724 The major causes may include genetic mutations and abnormal chromosomes. Exposure to X-rays, chemicals, drugs, pesticides, toxins, radiation, or viruses, increases the risk of anophthalmia and microphthalmia. Anophthalmia and microphthalmia lead to optic disc dysplasia as well as non-ocular features like mental retardation, neurological abnormalities, and facial dysmorphisms. The Global Anophthalmia and Microphthalmia Market growth is majorly attributed to the increasing prevalence of the genetic disorders and eye-related disorders. Moreover, the increasing mental retardation, neurological abnormalities are expected to drive the market growth over the assessment period. According to the World Health Organization (WHO), an estimated 253 million people live with vision impairment 36 million are blind and 217 million have moderate to severe vision impairment worldwide. An estimated 19 million children (below age 15) are vision impaired. Furthermore, According to the WHO estimates, neurological abnormalities are responsible for 4.5%-11% of all illnesses including low or high-income economies. The global anophthalmia and microphthalmia market is expected to grow at a CAGR of ~5.8 % during the forecast period 2017-2023. Global Anophthalmia and Microphthalmia Market -Segmentations The global anophthalmia and microphthalmia market is segmented on the basis by diagnosis, by treatment, and by the end user. On the basis of the diagnosis, it is segmented into CT scan, MR scan, chromosome analysis, ultrasonography, and others. On the basis of treatment, it is segmented into surgery and others.On the basis of the end user, it is segmented into hospitals & clinics, research centers, and others. Obtain Report Details with TOC @ https://www.marketresearchfuture.com/reports/anophthalmiaand-microphthalmia-market-4724 Global Anophthalmia and Microphthalmia Market -Regional Analysis
The Americas dominate the global anophthalmia and microphthalmia market owing to well-developed technology, increased patient pool with genetic disorders, high health care spending, and government support for research & development. Furthermore, increased R&D activities and the concentration of major companies have fuelled the growth of the market in this region. Europe holds the second position in the global anophthalmia and microphthalmia market owing to the government support for research & development and availability of funds for research. This is expected to continue to drive the European market over the forecasted period. Asia Pacific is the fastest growing anophthalmia and microphthalmia market owing to the presence of rapidly developing healthcare technology, huge patient population, and high healthcare expenditure. Moreover, increasing demand for new treatment methods in countries like India and South Korea is likely to emerge as the fastest growing market across the globe. On the other hand, in the Middle East and Africa, blood disorders have become a huge problem due to limited screening, ignorance of diseases, and poor access to treatment. Global Anophthalmia and Microphthalmia Market -Key Players Some of key the players in the market are Bristol-Myers Squibb Company, NUSAPURE, ALLERGAN, Aerie Pharmaceuticals, Inc., Pfizer Inc., Valeant Pharmaceuticals International, Inc., Bayer AG, Genentech, Inc., Novartis AG , Regeneron Pharmaceuticals, Inc., Shire, and Santen Pharmaceutical Co., Ltd., and others. Get Excusive Discount @ https://www.marketresearchfuture.com/check-discount/4724 Major Points form TOC for Anophthalmia and Microphthalmia Market Research Report – Forecast to 2023 Chapter 1. Report Prologue Chapter 2. Market Introduction Chapter 3. Research Methodology Chapter 4. Market Dynamics Chapter 5. Market Factor Analysis Chapter 6. Global Cancer Immunotherapy Market, By Type Chapter 7. Global Cancer Immunotherapy Market, By Treatment Chapter 8 Global Cancer Immunotherapy Market, By End User Chapter 9. Global Cancer Immunotherapy Market, By Region Chapter 10 Company Landscape Chapter 11 Company Profiles Chapter 12 MRFR Conclusion Chapter 13 Appendix About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Contact Us: Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar, Pune - 411028 Maharashtra, India Phone: +1 646 845 9312 Email: sales@marketresearchfuture.com